109 related articles for article (PubMed ID: 23827097)
21. Classical swine fever virus strain "C" protects the offspring by oral immunisation of pregnant sows.
Kaden V; Lange E; Steyer H; Lange B; Klopfleisch R; Teifke JP; Bruer W
Vet Microbiol; 2008 Jul; 130(1-2):20-7. PubMed ID: 18321665
[TBL] [Abstract][Full Text] [Related]
22. Control of classical swine fever epidemics under varying conditions--with special focus on emergency vaccination and rapid PCR testing.
Brosig J; Traulsen I; Krieter J
Transbound Emerg Dis; 2014 Jun; 61(3):258-65. PubMed ID: 23113941
[TBL] [Abstract][Full Text] [Related]
23. Using mortality data for early detection of Classical Swine Fever in The Netherlands.
Backer JA; Brouwer H; van Schaik G; van Roermund HJ
Prev Vet Med; 2011 Apr; 99(1):38-47. PubMed ID: 21081252
[TBL] [Abstract][Full Text] [Related]
24. Treatment with interferon-alpha delays disease in swine infected with a highly virulent CSFV strain.
Fernandez-Sainz I; Ramanathan P; O'Donnell V; Diaz-San Segundo F; Velazquez-Salinas L; Sturza DF; Zhu J; de los Santos T; Borca MV
Virology; 2015 Sep; 483():284-90. PubMed ID: 26004252
[TBL] [Abstract][Full Text] [Related]
25. Quantification of the effect of control strategies on classical swine fever epidemics.
Klinkenberg D; Everts-van der Wind A; Graat EA; de Jong MC
Math Biosci; 2003 Dec; 186(2):145-73. PubMed ID: 14583170
[TBL] [Abstract][Full Text] [Related]
26. Marker vaccine strategies and candidate CSFV marker vaccines.
Dong XN; Chen YH
Vaccine; 2007 Jan; 25(2):205-30. PubMed ID: 16934915
[TBL] [Abstract][Full Text] [Related]
27. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
[TBL] [Abstract][Full Text] [Related]
28. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.
Leifer I; Lange E; Reimann I; Blome S; Juanola S; Duran JP; Beer M
Vaccine; 2009 Nov; 27(47):6522-9. PubMed ID: 19732859
[TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
30. Modelling the effectiveness and risks of vaccination strategies to control classical swine fever epidemics.
Backer JA; Hagenaars TJ; van Roermund HJ; de Jong MC
J R Soc Interface; 2009 Oct; 6(39):849-61. PubMed ID: 19054739
[TBL] [Abstract][Full Text] [Related]
31. The role of movement restrictions and pre-emptive destruction in the emergency control strategy against CSF outbreaks in domestic pigs.
Thulke HH; Eisinger D; Beer M
Prev Vet Med; 2011 Apr; 99(1):28-37. PubMed ID: 21300412
[TBL] [Abstract][Full Text] [Related]
32. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission.
Lin GJ; Deng MC; Chen ZW; Liu TY; Wu CW; Cheng CY; Chien MS; Huang C
Vaccine; 2012 Mar; 30(13):2336-41. PubMed ID: 22300723
[TBL] [Abstract][Full Text] [Related]
33. [The Netherlands is ready to fight classical swine fever through vaccination].
Tijdschr Diergeneeskd; 2009 Jan; 134(1):20-1. PubMed ID: 19256216
[No Abstract] [Full Text] [Related]
34. Oral immunization of pigs against classical swine fever. Course of the disease and virus transmission after simultaneous vaccination and infection.
Kaden V; Schurig U; Steyer H
Acta Virol; 2001 Feb; 45(1):23-9. PubMed ID: 11394574
[TBL] [Abstract][Full Text] [Related]
35. Classical Swine Fever-An Updated Review.
Blome S; Staubach C; Henke J; Carlson J; Beer M
Viruses; 2017 Apr; 9(4):. PubMed ID: 28430168
[TBL] [Abstract][Full Text] [Related]
36. A serological study on infection patterns, control and persistence of classical swine fever in infected farms in the Philippines.
Geerts P; Pensaert M; Sanchez R
J Vet Med Sci; 1995 Oct; 57(5):917-20. PubMed ID: 8593302
[TBL] [Abstract][Full Text] [Related]
37. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
[TBL] [Abstract][Full Text] [Related]
38. Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes.
Suter R; Summerfield A; Thomann-Harwood LJ; McCullough KC; Tratschin JD; Ruggli N
Vaccine; 2011 Feb; 29(7):1491-503. PubMed ID: 21184857
[TBL] [Abstract][Full Text] [Related]
39. Protection of gruntlings against classical swine fever virus-infection after oral vaccination of sows with C-strain vaccine.
Kaden V; Lange E; Müller T; Teuffert J; Teifke JP; Riebe R
J Vet Med B Infect Dis Vet Public Health; 2006 Dec; 53(10):455-60. PubMed ID: 17123422
[TBL] [Abstract][Full Text] [Related]
40. Suitability of an E2 subunit vaccine of classical swine fever in combination with the E(rns)-marker-test for eradication through vaccination.
van Aarle P
Dev Biol (Basel); 2003; 114():193-200. PubMed ID: 14677689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
